Small Molecules

03 Feb 2007 Hollis-Eden Pharmaceuticals Presents Positive Data with HE3286 in Preclinical Model of Established Rheumatoid Arthritis
03 Feb 2007 FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
03 Feb 2007 GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
03 Feb 2007 Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel® (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
02 Feb 2007 Metabasis Announces Completion of Enrollment in the Phase 2b Clinical Trial for CS-917 in Patients With Type 2 Diabetes
02 Feb 2007 Neurochem announcement regarding the completion of its North American Phase III clinical trial for tramiprosate (ALZHEMEDâ„¢) for the treatment of Alzheimer's disease
02 Feb 2007 Preliminary clinical data for mecamylamine (AGI-004) and arbaclofen (AGI-006)
01 Feb 2007 AstraZeneca and Palatin Technologies Announce Worldwide Collaboration to Discover, Develop and Commercialise Obesity Compounds
01 Feb 2007 Lab International Initiates Patient Enrollment In The Extension Of Its Phase IIB Fentanyl Taifun(R) Trial
01 Feb 2007 Curis, Inc. Announces Dosing of First Patient in Hedgehog Antagonist Phase I Clinical Trial
01 Feb 2007 Pharmion Announces FDA Acceptance of IND for Oral Azacitidine
01 Feb 2007 Theratechnologies launches confirmatory Phase 3 trial testing TH9507
01 Feb 2007 NeuroDerm's Transdermal L-DOPA Parkinson’s Patch Completes First Clinical Trial
01 Feb 2007 Polydex Pharmaceuticals Drug Trial Halted After HIV Risk Seen
01 Feb 2007 Athenagen’s Eye Drop Therapy for AMD is Safe and Well Tolerated in Phase I Study
01 Feb 2007 Gemin X Initiates Phase 1/2 Combination Trials with GX15-070 in Non-Small Cell Lung Cancer and Mantle Cell Lymphoma
01 Feb 2007 Nexmed Announces Patient Dosing In Phase 3 Program For Anti-Fungal Product
31 Jan 2007 Exelixis Files IND Application for XL418
31 Jan 2007 First Subjects Dosed in Phase l Trial of Triple Action Agent Tyrima
31 Jan 2007 Debiopharm Signs R&D And Commercialisation Agreement With Kirin For The Development Of DEBIO-0719 In Oncology
31 Jan 2007 Immtech Completes Enrollment in Phase III Pivotal Trial of Pafuramidine for African Sleeping Sickness
31 Jan 2007 Innovative Long-Acting Contraceptive Product Mirena(R) approved in Japan
31 Jan 2007 Proton Pump Inhibitor Pariet(R) Tablets 10mg Receives Approval in Japan
31 Jan 2007 Lexicon Advances LX6171 for Cognitive Disorders into Phase 1b Clinical Trial
31 Jan 2007 Vistagen's AV-101 Drug Candidate Yields Positive Preclinical Data For Neuropathic Pain Applications

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up